Chromogranin A and serotonin for evaluation of treatment efficacy of neuroendocrine tumors

Chromogranin A and serotonin for evaluation of treatment efficacy of neuroendocrine tumors

Background: The utility of biochemical markers in the monitoring of treatment efficacy in patients with neuroendocrine tumors (NETs) goes beyond any doubt. However, there are still no clear criteria for the assessment of clinically significant abnormalities of the main NET biomarkers chromogranin A...

Full description

Bibliographic Details
Main Authors:	N. V. Lyubimova, Yu. S. Timofeev, T. K. Churikova, A. A. Markovich, G. S. Emelianova, I. S. Stilidi, N. E. Kushlinskii
Format:	Article
Language:	Russian
Published:	MONIKI 2020-01-01
Series:	Alʹmanah Kliničeskoj Mediciny
Subjects:	neuroendocrine tumor chemotherapy monitoring biomarker chromogranin a serotonin
Online Access:	https://www.almclinmed.ru/jour/article/view/1147

Similar Items

CLINICAL VALUE OF CHROMOGRANIN A IN GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS
by: N. V. Lyubimova, et al.
Published: (2016-02-01)

Serum Chromogranin Level in Gastrointestinal, Pancreas, and Liver Neuroendocrine Tumors: A Brief Report
by: Mahboubeh Azema, et al.
Published: (2022-01-01)

Prognostic significance of dynamics of biochemical markers of neuroendocrine tumors during treatment with biotherapy
by: G S Emelianova, et al.
Published: (2014-06-01)

Neuroendocrine tumors: Laboratory diagnosis
by: Tzontcheva Anna
Published: (2010-01-01)

Chromogranin A: As A Tumor Marker for Neuroendocrine Tumors Diagnosis, Follow-up & Its Correlation with Response to Somatostatin Analogues
by: Manwar A. Mohammed AL-Naqqash
Published: (2016-01-01)

Significance of chromogranin A and synaptophysin in pancreatic neuroendocrine tumors
by: Tatsuo Tomita
Published: (2020-08-01)

Performance Evaluation of the KRYPTOR Compact PLUS Analyzer-Based B.R.A.H.M.S. CgA Ⅱ KRYPTOR Assay for Chromogranin A Measurement
by: Yu Jeong Choi, et al.
Published: (2021-12-01)

The Prognostic and Predictive Role of Chromogranin A in Gastroenteropancreatic Neuroendocrine Tumors – A Single-Center Experience
by: Hui-Jen Tsai, et al.
Published: (2021-11-01)

Neuroendocrine Carcinoma of Breast: A Rare Case Vignette
by: Nandeesh M., et al.
Published: (2013-11-01)

Chromogranin A as a Biochemical Marker for Neuroendocrine Tumors: A Single Center Experience at Royal Hospital, Oman
by: Elham S. Al-Risi, et al.
Published: (2017-09-01)

Limited Diagnostic Utility of Chromogranin A Measurements in Workup of Neuroendocrine Tumors
by: Jonas Baekdal, et al.
Published: (2020-10-01)

Circulating Neuroendocrine Tumor Biomarkers: Past, Present and Future
by: Paweł Komarnicki, et al.
Published: (2022-09-01)

The neuroendocrine markers assay and the glycemia profile in patients with neuroendocrine tumors under octreotide therapy: a 2 years study / Determinarea markerilor neuroendocrini şi a profilului glicemic la pacienţii cu tumori neuroendocrine în tratament cu octreotid
by: Poiană Cătălina, et al.
Published: (2014-09-01)

Histopathological Chromogranin A-Positivity Is Associated with Right-Sided Colorectal Cancers and Worse Prognosis
by: Zoltan Herold, et al.
Published: (2020-12-01)

Analytical aspects of gastrin measurement in neuroendocrine tumors
by: N. V. Lyubimova, et al.
Published: (2018-08-01)

Chromogranin A: Novel biomarker between periodontal disease and psychosocial stress
by: Arunima Padmakumar Reshma, et al.
Published: (2013-01-01)

Primary neuroendocrine carcinoma of the breast
by: Akhtar Kafil, et al.
Published: (2009-01-01)

P53, Somatostatin receptor 2a and Chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasms
by: Kirstine Nielsen, et al.
Published: (2020-01-01)

The Clinico-epidemiologic Characteristics of Iraqi Patients with Neuroendocrine Tumors and Their Response to Long Acting Octreotide
by: Marwah K. Abdulfattah, et al.
Published: (2016-01-01)

Comparison of PCR-based detection of chromogranin A mRNA with traditional histological lymph node staging of small intestinal neuroendocrine neoplasia
by: Lawrence Ben, et al.
Published: (2012-06-01)

Blood Transcript Profiling for the Detection of Neuroendocrine Tumors: Results of a Large Independent Validation Study
by: Mark J. C. van Treijen, et al.
Published: (2018-12-01)

BIOCHEMICAL MARKERS IN SERUM AND URINE IN THE WORKUP OF PATIENTS WITH NEUROENDOCRINE TUMORS
by: N. V. Lyubimova, et al.
Published: (2016-12-01)

Cystic Pancreatic Neuroendocrine Tumor: A Diagnostic Dilemma
by: Md Ali Osama, et al.
Published: (2023-03-01)

Prognostic value of chromogranin A in patients with GET/NEN in the pancreas and the small intestine
by: Małgorzata Fuksiewicz, et al.
Published: (2018-06-01)

Chromogranin A as Serum Marker for Gastroenteropancreatic Neuroendocrine Tumors: A Single Center Experience and Literature Review
by: Christoph J. Auernhammer, et al.
Published: (2012-02-01)

Prognostic impact of chromogranin A in patients with acute heart failure
by: Hong Nyun Kim, et al.
Published: (2021-10-01)

Predictors of Outcomes in Gastric Neuroendocrine Tumors: A Retrospective Cohort
by: Raquel Ortigão, et al.
Published: (2023-07-01)

Editorial: Neuroendocrine tumors of the gastrointestinal tract, liver, and pancreas: current management and treatment strategies
by: Alexandros Giakoustidis, et al.
Published: (2023-05-01)

Selected Serum Biomarkers (Leptin, Chromogranin A, CA19-9, CEA) in Patients with Pancreatic Neuroendocrine Neoplasm and Associations with Metabolic Syndrome
by: Violetta Rosiek, et al.
Published: (2023-04-01)

Chromogranin A: An Endocrine Factor of Pregnancy
by: Michalina Bralewska, et al.
Published: (2023-03-01)

Serum chromogranin A correlated with albuminuria in diabetic patients and is associated with early diabetic nephropathy
by: Hui Yu, et al.
Published: (2022-01-01)

Bone metastases from neuroendocrine tumors: clinical and biological considerations
by: Matteo Scopel, et al.
Published: (2022-06-01)

Efficacy of somatostatine analogues in survival and quality of life of a frail patient with poorly differentiated biliary neuroendocrine tumour
by: Marco Alì, et al.
Published: (2015-10-01)

Primary neuroendocrine tumors of the breast: two case reports and review of the literature
by: Loubna Hejjane, et al.
Published: (2020-03-01)

Primary Paraganglioma of the Thyroid Gland- A Rare Case Report
by: Manjot Gill, et al.
Published: (2017-12-01)

Comparison of two chromogranin A assays and investigation of nonlinear specimens
by: J. Alan Erickson, et al.
Published: (2022-11-01)

Chromogranin A in the Laboratory Diagnosis of Pheochromocytoma and Paraganglioma
by: Radovan Bílek, et al.
Published: (2019-04-01)

Serotonin-Secreting Neuroendocrine Tumours of the Pancreas
by: Anna Caterina Milanetto, et al.
Published: (2020-05-01)

Salivary cortisol, dehydroepiandrosterone, and chromogranin A levels in patients with gingivitis and periodontitis and a novel biomarker for psychological stress
by: Yeon-Hee Lee, et al.
Published: (2023-04-01)

Chromogranin A in diagnosis of pheochromocytoma (comparative analysis)
by: Marina Yu. Yukina, et al.
Published: (2021-04-01)